Colorectal cancer
Colorectal cancer
Cetuximab
Cetuximab
NICE appraisal
NICE appraisal
TA176 Cetuximab for the first line treatment of metastatic colorectal cancer (August 2009)
DSU reports
DSU reports
Cetuximab for the first line treatment of metastatic colorectal cancer: addendum (PDF, 11KB) (May 2009)
Cetuximab for the first line treatment of metastatic colorectal cancer (PDF, 99KB) (March 2009)